These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 21224838

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Evaluation of treatment pattern and symptom control in patients with gastroesophageal reflux disease: multihospital questionnaire survey on the current situation in Korea.
    Seo SI, Bang CS, Kang HS, Choi MH, Shin WG, Jang HJ, Kim JB, Baik KH, Kae SH, Kim HY.
    Dis Esophagus; 2017 Oct 01; 30(10):1-8. PubMed ID: 28859382
    [Abstract] [Full Text] [Related]

  • 23. Dexlansoprazole for the treatment of esophagitis and GERD.
    Davies SL.
    Drugs Today (Barc); 2010 Feb 01; 46(2):75-80. PubMed ID: 20393635
    [Abstract] [Full Text] [Related]

  • 24. Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease.
    Gold BD, Pilmer B, Kierkuś J, Hunt B, Perez MC, Gremse D.
    Dig Dis Sci; 2017 Nov 01; 62(11):3059-3068. PubMed ID: 28916953
    [Abstract] [Full Text] [Related]

  • 25. Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD.
    Brozek JL, Guyatt GH, Heels-Ansdell D, Degl'Innocenti A, Armstrong D, Fallone CA, Wiklund I, van Zanten SV, Chiba N, Barkun AN, Akl EA, Schünemann HJ.
    J Clin Epidemiol; 2009 Jan 01; 62(1):102-10. PubMed ID: 18619804
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Dexlansoprazole: A proton pump inhibitor with a dual delayed-release system.
    Emerson CR, Marzella N.
    Clin Ther; 2010 Aug 01; 32(9):1578-96. PubMed ID: 20974316
    [Abstract] [Full Text] [Related]

  • 29. Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.
    Cadiot G, Delaage PH, Fabry C, Soufflet C, Barthélemy P.
    Dig Liver Dis; 2011 Oct 01; 43(10):784-7. PubMed ID: 21752736
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Sleep disturbances and refractory gastroesophageal reflux disease symptoms in patients receiving once-daily proton pump inhibitors and efficacy of twice-daily rabeprazole treatment.
    Fujiwara Y, Habu Y, Ashida K, Kusano M, Higuchi K, Arakawa T.
    Digestion; 2013 Oct 01; 88(3):145-52. PubMed ID: 24008338
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The proton pump inhibitor test for gastroesophageal reflux disease: optimal cut-off value and duration.
    de Leone A, Tonini M, Dominici P, Grossi E, Pace F, EMERGE Study Group.
    Dig Liver Dis; 2010 Nov 01; 42(11):785-90. PubMed ID: 20452300
    [Abstract] [Full Text] [Related]

  • 34. Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring.
    Shimatani T, Sugimoto M, Nishino M, Adachi K, Furuta K, Ito M, Kurosawa S, Manabe N, Mannen K, Hongo M, Chiba T, Kinoshita Y, Acid-Related Symptom Research (ARS) Group.
    J Gastroenterol Hepatol; 2012 May 01; 27(5):899-906. PubMed ID: 22098590
    [Abstract] [Full Text] [Related]

  • 35. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
    Miner PB, McKean LA, Gibb RD, Erasala GN, Ramsey DL, McRorie JW.
    Aliment Pharmacol Ther; 2010 Apr 01; 31(8):846-51. PubMed ID: 20146702
    [Abstract] [Full Text] [Related]

  • 36. Consequences of frequent nocturnal gastro-oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity.
    Dubois RW, Aguilar D, Fass R, Orr WC, Elfant AB, Dean BB, Harper AS, Yu HT, Melmed GY, Lynn R, Singh A, Tedeschi M.
    Aliment Pharmacol Ther; 2007 Feb 15; 25(4):487-500. PubMed ID: 17270005
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
    Pace F, Pace M.
    Expert Rev Gastroenterol Hepatol; 2010 Aug 15; 4(4):423-7. PubMed ID: 20678016
    [Abstract] [Full Text] [Related]

  • 39. Dexlansoprazole MR: a review.
    Hershcovici T, Jha LK, Fass R.
    Ann Med; 2011 Aug 15; 43(5):366-74. PubMed ID: 21366513
    [Abstract] [Full Text] [Related]

  • 40. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM, McIntyre L, Bernard L, Fendrick AM.
    Am J Gastroenterol; 2003 Sep 15; 98(9):1940-4. PubMed ID: 14499769
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.